0
Eton Pharmaceuticals, Inc. Banner Image

Eton Pharmaceuticals, Inc. has reached its limit for free report views

Work for Eton Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Eton Pharmaceuticals, Inc.

  • Ticker ETON
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eton Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Deer Park, Illinois
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, acquiring, and commercializing pediatric rare disease products. The company’s first commercial product, Biorphen, is the only FDA approved ready-to-use formulation of phenylephrine injection and was launched in December 2019. The company’s lead pediatric product is the orphan drug Alkindi® SprinkleMore, which is currently under review with the FDA. The company has an additional seven products under development, including five that are under review with the FDA.
Eton Pharmaceuticals, Inc.

Most Recent Annual Report

Eton Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Eton Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports